` Comparison: SANN vs PNEXF - Alpha Spread

S
SANN
vs
PNEXF

Over the past 12 months, SANN has outperformed PNEXF, delivering a return of +2% compared to the PNEXF's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
SANN
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

S
SANN Intrinsic Value
Not Available
PNEXF Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
S
Santhera Pharmaceuticals Holding AG
SIX:SANN
16.66 CHF
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
SANN, PNEXF

SANN
PNEXF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
S
Santhera Pharmaceuticals Holding AG
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
SANN, PNEXF

SANN
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
S
Santhera Pharmaceuticals Holding AG
SIX:SANN
Pharnext SCA
OTC:PNEXF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

SANN
13.4%
PNEXF
0%

Operating Margin

SANN
-103.7%
PNEXF
-17 526.7%

Net Margin

SANN
-133.7%
PNEXF
-21 040%

FCF Margin

SANN
-83.6%
PNEXF
-15 953.3%

ROE

SANN
-136.4%
PNEXF
114.6%

ROA

SANN
-60.6%
PNEXF
-391.1%

ROIC

SANN
-66.4%
PNEXF
3 092.9%

ROCE

SANN
-92.1%
PNEXF
275.4%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
SANN, PNEXF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SANN, PNEXF

Loading
SANN
PNEXF
Difference
www.alphaspread.com

Performance By Year
SANN, PNEXF

Loading
SANN
PNEXF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare SANN to other stocks
ABBV
Abbvie Inc
Cheaper
vs SANN
ATXS
Astria Therapeutics Inc
Cheaper
vs SANN
AMGN
Amgen Inc
Cheaper
vs SANN
GILD
Gilead Sciences Inc
Cheaper
vs SANN
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett